UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934
JUNE 8, 2000
------------------
(Date of earliest event reported)
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 1-11353 13-3757370
-------------- ----------- --------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
-------------------------------------------------------
(Address of principal executive offices)
336-229-1127
------------
(Registrant's telephone number, including area code)
ITEM 5. OTHER EVENTS
On June 8, 2000, Laboratory Corporation of America-
Registered Trademark- Holdings (LabCorp-Registered Trademark-
) announced that its Board of Directors has declared a
dividend of $0.08264 per share on the Company's Series A
Preferred Stock, payable in cash. The Board has also
declared a dividend of $0.08264 per share on the Company's
Series B Preferred Stock, payable in shares of Series B
Preferred Stock at the rate of 0.001653 shares per share of
Series B Preferred Stock held. The dividends will be paid on
June 30, 2000 for each issued and outstanding share of
Series A and Series B Preferred Stock to stockholders of
record on June 14, 2000 (whether or not such stockholders
convert their shares after such date), and will cover the
seven days to July 7, 2000, the date set for redemption of
the Series A and Series B Preferred Stock, at an equivalent
annualized rate of $4.25 per share. The dividends will be
paid in addition to the dividends payable on the Series A
and Series B Preferred Stock for the quarterly dividend
period ended June 30, 2000 announced by the Company on May
2, 2000.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL
INFORMATION AND EXHIBITS
(c) Exhibit
20 Press release of the Company dated
June 8, 2000.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange
Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Registrant)
By:/s/ BRADFORD T. SMITH
------------------------------
Bradford T. Smith
Executive Vice President,
General Counsel, Secretary
and Compliance Officer
Date: June 12, 2000
Laboratory Corporation of America-Registered Trademark-Holdings
358 South Main Street
Burlington, NC 27215
Telephone: 336-584-5171
FOR IMMEDIATE RELEASE
Contact: 336-436-4855 Shareholder Direct: 800-LAB-0401
Pamela Sherry www.labcorp.com
LABORATORY CORPORATION OF AMERICA-REGISTERED TRADEMARK- DECLARES
FINAL PREFERRED STOCK DIVIDENDS
Burlington, NC, June 8, 2000 - Laboratory Corporation of America-
Registered Trademark- Holdings (LabCorp-Registered Trademark-) (NYSE:
LH) today announced that its Board of Directors has declared a
dividend of $0.08264 per share on the Company's Series A Preferred
Stock, payable in cash. The Board has also declared a dividend of
$0.08264 per share on the Company's Series B Preferred Stock, payable
in shares of Series B Preferred Stock at the rate of 0.001653 shares
per share of Series B Preferred Stock held. No fractional shares of
Series B Preferred Stock will be issued, so that the number of shares
to be paid as a dividend on the Series B Preferred Stock will be
rounded to the nearest whole number of shares. The dividends will be
paid on June 30, 2000, for each issued and outstanding share of
Series A and Series B Preferred Stock to stockholders of record on
June 14, 2000 (whether or not such stockholders convert their shares
after such date), and will cover the seven days to July 7, 2000, the
date set for redemption of the Series A and Series B Preferred Stock,
at an equivalent annualized rate of $4.25 per share. The dividends
will be paid in addition to the dividends payable on the Series A and
Series B Preferred Stock for the quarterly dividend period ended June
30, 2000 announced by the Company on May 2, 2000.
Laboratory Corporation of America-Registered Trademark- Holdings
(LabCorp-Registered Trademark-) is a national clinical laboratory
with annual revenues of $1.7 billion in 1999. With 18,000 employees
and over 100,000 clients nationwide, the Company offers more than
2,000 clinical tests ranging from simple blood analyses to
sophisticated molecular diagnostics. LabCorp leverages its expertise
in innovative clinical testing technology with three Centers of
Excellence. The Center for Molecular Biology and Pathology, in
Research Triangle Park (RTP), North Carolina, develops applications
for polymerase chain reaction (PCR) technology. Its Center for
Occupational Testing in RTP is the world's largest substance abuse
testing facility, and the Center for Esoteric Testing in Burlington,
North Carolina, performs the largest volume of specialty testing in
the network. LabCorp's clients include physicians, state and federal
government, managed care organizations, hospitals, clinics,
pharmaceutical and Fortune 1000 companies, and other clinical
laboratories.
_______________________________